Teva plans to close Montreal plant

Teva Pharmaceutical Industries will divest itself of a Montreal-based plant it inherited from its buyout of Ratiopharm last year. The plant, which employs 340 people, has already been put up for sale. But if no buyers emerge, layoffs will begin next March. Report

Suggested Articles

An online pharmacy has again criticized FDA action after tipping off regulators to the existence of a dangerous impurity in Zantac and other antacids.

A group of senators is asking the FTC to take a careful look at pharma mergers given the cost of drugs in the U.S.

Life’s been tough for J&J's prostate cancer med Erleada in its battle with Pfizer-Astellas’ Xtandi. A new FDA nod could help level the playing field.…